Labshake search
Citations for Stemcell Technologies :
1 - 50 of 256 citations for Kanamycin kinase type II NEO Klebsiella pneumoniae since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: ... 1G4 PBMCs loaded onto pMHC nanovials were sorted based on calcein AM and NGFR signal and reconstituted with 0.75 mL media and 0.25 mL of 10 mg/mL Collagenase Type II solution (STEMCELL Technologies), followed by a 2 hour incubation at 37°C ...
-
bioRxiv - Molecular Biology 2024Quote: ... a Rho-associated kinase (ROCK) inhibitor (StemCell Technologies), to promote cell survival ...
-
bioRxiv - Cell Biology 2020Quote: ... Rho-kinase inhibitor Y-27632 (STEMCELL Technologies, 20 µM), MLCK inhibitor ML-7 (Enzo ...
-
bioRxiv - Molecular Biology 2023Quote: ... Rho-associated kinase (ROCK)-Inhibitor (StemCell Technologies, Y-27632) was added to mTeSR at 10 µM ...
-
bioRxiv - Synthetic Biology 2021Quote: ... neural maintenance media with Rho Kinase Inhibitor IV (Stemcell Technologies Australia ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant Fms-like tyrosine kinase-3 (Flt3, StemCell Technologies Cat#78009), Erythropoeitin (EPO ...
-
bioRxiv - Immunology 2019Quote: ... Collagenase Type IV (STEMCELL Technologies, Catalog #07909); ROCKi ...
-
bioRxiv - Cell Biology 2022Quote: ... and plated in media containing 10 μM Rho-kinase inhibitor Y-27632 (StemCell Technologies). Embryonic body (EB ...
-
bioRxiv - Neuroscience 2021Quote: ... and media with 10 μM Rho-associated kinase (ROCK) inhibitor (Y-27632, STEMCELL Technologies) was used for any single-cell dissociation ...
-
bioRxiv - Bioengineering 2021Quote: ... coiled-coil containing protein kinase (ROCK) inhibitor (5 μM, StemCell Technologies, Vancouver, BC, Canada). Until 95% confluency was reached ...
-
bioRxiv - Developmental Biology 2023Quote: ... supplemented with 10 μM Rho-kinase inhibitor (RockI; Y-27632 STEMCELL Technologies, cat. 72304). iPSCs were seeded at a density of 6×104 cells/cm2 and expanded for 3 days to achieve 80% confluency prior to differentiation ...
-
bioRxiv - Cancer Biology 2022Quote: ... or StemSpan Serum Free Expansion Media II (SFEM II) (Stem Cell Technologies), supplemented with human stem cell factor (SCF ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 2 μl/mL Rho-kinase inhibitor (RockI; Y-27632 STEMCELL Technologies, cat. 72304). To prepare the differentiation experiments ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 50 μM Rho-associated protein kinase (ROCK) inhibitor Y-27632 (Stem Cell Technologies). The cell suspension was distributed into ultra-low attachment 96-well plates (Corning) ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5 mg/ mL Collagenase Type IV (Stem Cell Technologies), 250 U/ mL Deoxyribonuclease I (Worthington Biochemical Corporation ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5 mg/mL Collagenase Type IV (Stem Cell Technologies), 250 U/mL Deoxyribonuclease I (Worthington Biochemical Corporation ...
-
Efficient Methods for Target Gene Manipulation in Haematopoietic Stem Cell Derived Human NeutrophilsbioRxiv - Cell Biology 2023Quote: ... 40% SFEM II (StemCell Technologies) and 10% DMSO (Sigma-Aldrich).
-
bioRxiv - Developmental Biology 2019Quote: ... embryos were treated with Collagenase Type I (Stemcell technologies; 07902) at 0,125% for 1h at 37º ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μg/ml collagen type I (Stemcell Technologies, Catalog # 07001), 50 μg/ml penicillin/streptomycin ...
-
bioRxiv - Bioengineering 2024Quote: ... Cells were cultured in StemSpan™ Serum-Free Expansion Medium version II (SFEM II; STEMCELL Technologies) containing 50 ng/mL each of recombinant human stem cell factor (SCF ...
-
bioRxiv - Immunology 2021Quote: ... Selection kit II (STEMCELL Technologies, #17877) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2022Quote: ... StemSpan SFEM II (Stem Cell Technologies) supplemented with recombinant 50 ng/mL SCF and FLT3-L ...
-
bioRxiv - Bioengineering 2024Quote: ... containing StemSpan SFEM II (StemCell Technologies) supplemented with penicillin/streptomycin (100 U/mL ...
-
bioRxiv - Developmental Biology 2023Quote: ... and kept on Rho-associated protein kinase (ROCK) inhibitor Y-27632 (final concentration 5 μM, StemCell Technologies, #72302) for one day ...
-
bioRxiv - Cell Biology 2023Quote: ... with StemSpan SFEM II containing 1% Penicillin Streptomycin and the StemSpan Myeloid Expansion Supplement II (StemCell Technologies). At day 15 ...
-
bioRxiv - Neuroscience 2023Quote: ... hiPSCs were dissociated with Collagenase Type IV (STEMCELL Technologies, Catlog #07909). Differentiation media contain growth factors and small molecule including SHH (100 ng/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... Cells were cultured in mTeSR plus medium supplemented with 10 µM Rho-associated protein kinase (ROCK) inhibitor (Stemcell Technologies). After overnight incubation ...
-
bioRxiv - Developmental Biology 2020Quote: ... Dispase II (2.5 U/mL; STEMCELL Technologies), fatty acid free bovine serum albumin (2% ...
-
bioRxiv - Molecular Biology 2022Quote: ... 1U/ml Dispase II (STEMCELL Technologies, 07913), and 0.1mg/ml DNase I (Sigma ...
-
bioRxiv - Microbiology 2022Quote: ... 0.5 U/mL Dispase II (StemCell Technologies), and 50 μg/mL DNase (Alfa Aesar ...
-
bioRxiv - Systems Biology 2022Quote: ... Dispase II (2.5 U/mL; STEMCELL Technologies), fatty acid-free bovine serum albumin (2% ...
-
bioRxiv - Developmental Biology 2023Quote: ... StemSpan™ SFEM II (#09605, STEMCELL Technologies) supplemented with StemSpan™ Erythroid Expansion Supplement (100X ...
-
bioRxiv - Neuroscience 2021Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Immunology 2020Quote: ... PBMCs were resuspended in SFEM II (StemCell Technologies) with 5 μg/mL purified anti-CD28 (clone CD28.2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Bioengineering 2023Quote: Bone marrow-derived human CD34+ stem cells were purchased from Stemcell technologies and cultured in SFEM II medium (Stemcell technologies) containing 100 μM SCF (Stemcell technologies ...
-
bioRxiv - Bioengineering 2024Quote: ... and 1X Myeloid Expansion Supplement II (StemCell Technologies). Cells were maintained for up to three weeks in the same plates and split every three to four days by discarding 160 μL of medium and adding 160 μL of fresh differentiation medium to each well.
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
Stem cell-derived macrophages as a new platform for studying host-pathogen interactions in livestockbioRxiv - Immunology 2021Quote: ... Cells were plated at a density of 2-3×103/cm2 in pEPSCM medium27 containing the Rho-associated coiled kinase (ROCK) inhibitor Y-27632 (5μM, Stemcell Technologies, #72304). Cells were fed the following day with pEPSCM without Y-27632 then fed daily ...
-
bioRxiv - Cell Biology 2021Quote: ... Cells were re-plated in mTeSR1 medium supplemented with 1% penicillin-streptomycin (Thermo Fischer Scientific) and 10 mM Rho-associated protein kinase (ROCK) inhibitor (Stemolecule Y-27632, STEMCELL Technologies) for 24 hr ...
-
bioRxiv - Bioengineering 2020Quote: ... the hiPSCs were collected and seeded at 1.5 × 105 cells/cm2 cell density on glass coverslips with Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor supplemented mTeSR media (5 μM, StemCell Technologies). The culture was maintained with daily media changes until 90% confluency was reached ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Bioengineering 2023Quote: ... and then incubated overnight in media supplemented with 5 µM of the Rho-associated protein kinase (ROCK) inhibitor Y-27632 (STEMCELL Technologies).
-
bioRxiv - Bioengineering 2023Quote: ... to 1 volume of CellAdhere™ type I bovine (STEMCELL Technologies, Cat# 07001) we added 8/10 volume of DMEM ...
-
bioRxiv - Cancer Biology 2022Quote: ... The t(8;21)-positive patient primary cells were co-cultured on MSCs feeders and cultivated with SFEM II containing 1X Human Myeloid Expansion Supplement II (StemCell Technologies).
-
bioRxiv - Genetics 2022Quote: ... HSPCs were transferred into erythroid differentiation medium (EDM) consisting of StemSpan serum-free expansion medium II(SFEM II; Stem Cell Technologies) with 1% penicillin/streptomycin (Thermo Fisher Scientific) ...
-
bioRxiv - Genomics 2021Quote: ... after which cells were replated in E8 containing p160-Rho-associated coiled-coil kinase (ROCK) inhibitor Y-27632 (2 μM; Stemcell Tech, 72307).
-
bioRxiv - Cell Biology 2019Quote: ... cells were harvested with GCDR and plated in Essential-E8 supplemented with 10 uM Rho-kinase inhibitor Y27632 (Stem Cell Technologies, 72304) on VTN coated 6-well culture dish to yield approximately 80% confluence next day ...
-
bioRxiv - Developmental Biology 2020Quote: ... Cells were passaged in clumps of 8-10 cells and seeded in mTeSR supplemented with the Rho-associated protein kinase inhibitor γ-27632 (STEMCELL Technologies) at 10 µM for the first day to improve survival ...
-
bioRxiv - Developmental Biology 2023Quote: ... The cell culture medium was supplemented with 1:200 Rho-associated protein kinase inhibitor (ROCKi) Y-27632 (final concentration 5 µM, STEMCELL Technologies, 72302) on the first day after passage ...